Claims for Patent: 10,927,258
✉ Email this page to a colleague
Summary for Patent: 10,927,258
Title: | Process for the preparation of Indigotindisulfonate sodium (indigo carmine) |
Abstract: | This invention relates to an improved method for the preparation of highly or substantially pure Indigotindisulfonate sodium (1). It further relates to the novel crystalline form I of Indigotindisulfonate sodium (1) and the process for its preparation. |
Inventor(s): | Pullagurla; Manik Reddy (Hyderabad, IN), Rangisetty; Jagadeesh Babu (Hyderabad, IN) |
Assignee: | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (Hyderabad, IN) |
Application Number: | 16/471,999 |
Patent Claims: |
1. An improved process for the preparation of Indigotindisulfonate sodium having purity greater than 99.0% comprising the steps of: ##STR00007## i. treating a
2-nitrobenzaldehyde (2) ##STR00008## with base to give a 2,2'-biindolylidene-3,3'-dione (3); ##STR00009## ii. sulphonating the 2,2'-biindolylidene-3,3'-dione (3) by treating with concentrated sulphuric acid followed by pH adjustment with sodium
hydroxide to obtain crude Indigotindisulfonate sodium (1); and iii. purifying the crude Indigotindisulfonate sodium (1) to give pure Indigotindisulfonate sodium (1), wherein the purification process comprises: a. suspending crude Indigotindisulfonate
sodium (1) in protic or aprotic solvent; b. heating the suspension to 60-65.degree. C.; c. cooling the suspension to 20-25.degree. C.; and d. filtering the suspension and washing with methanol at 20-25.degree. C. to isolate pure crystalline
Indigotindisulfonate sodium (1).
2. The process as claimed in claim 1, wherein the base used in step i) is selected from the group consisting of sodium hydroxide, sodium carbonate, sodium bicarbonate or the like. 3. The process as claimed in claim 1, wherein the pH in step ii) is maintained above 13 by using sodium hydroxide. 4. The process as claimed in claim 1, wherein the protic or aprotic solvent is selected from the group consisting of water, methanol, ethanol, isopropanol, n-butanol, acetonitrile, tetrahydrofuran, acetone, ethyl acetate, dichloromethane or mixtures thereof. 5. A process for the purification of Indigotindisulfonate sodium comprising: a. suspending crude Indigotindisulfonate sodium (1) in protic or aprotic solvent; b. heating the suspension to 60-65.degree. C.; c. cooling the suspension to 20-25.degree. C.; and d. filtering the suspension and washing with methanol at 20-25.degree. C. to isolate pure crystalline Indigotindisulfonate sodium (1). 6. The process as claimed in claim 5, wherein the protic or aprotic solvent is selected from the group consisting of water, methanol, ethanol, isopropanol, n-butanol, acetonitrile, tetrahydrofuran, acetone, ethyl acetate, dichloromethane or mixtures thereof. 7. A crystalline form I of Indigotindisulfonate sodium wherein X-ray powder diffraction (XRPD) pattern as shown in FIG. 1 having peaks at 2 theta values 5.8, 11.67, 15.37, 17.62, 20.31 and 26.54.+-.0.2.degree. ##STR00010## |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.